gabexate has been researched along with Lupus Erythematosus, Systemic in 3 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of disseminated intravascular coagulation (DIC) in a patient with systemic lupus erythematosus (SLE) with acute liver dysfunction is described." | 2.38 | Disseminated intravascular coagulation in lupus erythematosus with acute liver damage. ( Kaneda, S; Sano, M; Shimamoto, Y; Tsunada, S; Yamaguchi, M; Yamamoto, K, 1992) |
| "This is the first case report of severe acute pancreatitis in the setting of overlap syndrome of SLE and SSc." | 1.33 | A case of severe acute pancreatitis, in overlap syndrome of systemic sclerosis and systemic lupus erythematosus, successfully treated with plasmapheresis. ( Hara, M; Kamatani, N; Koizumi, K; Okamoto, H; Suzuki, Y; Tateishi, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, Y | 1 |
| Okamoto, H | 1 |
| Koizumi, K | 1 |
| Tateishi, M | 1 |
| Hara, M | 1 |
| Kamatani, N | 1 |
| Ueda, Y | 1 |
| Nagasawa, K | 1 |
| Tsukamoto, H | 1 |
| Horiuchi, T | 1 |
| Yoshizawa, S | 1 |
| Tsuru, T | 1 |
| Furugo, I | 1 |
| Niho, Y | 1 |
| Shimamoto, Y | 1 |
| Sano, M | 1 |
| Kaneda, S | 1 |
| Tsunada, S | 1 |
| Yamamoto, K | 1 |
| Yamaguchi, M | 1 |
1 review available for gabexate and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Disseminated intravascular coagulation in lupus erythematosus with acute liver damage.
Topics: Adult; Antithrombin III; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Gabexate | 1992 |
1 trial available for gabexate and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Urinary C4 excretion in systemic lupus erythematosus.
Topics: Adolescent; Adult; Blotting, Western; Complement Activation; Complement C4; DNA; Esters; Female; Gab | 1995 |
1 other study available for gabexate and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
A case of severe acute pancreatitis, in overlap syndrome of systemic sclerosis and systemic lupus erythematosus, successfully treated with plasmapheresis.
Topics: Adult; Anti-Inflammatory Agents; Female; Gabexate; Humans; Lupus Erythematosus, Systemic; Methylpred | 2006 |